Latest Director Loans News

Askari Metals cut its annual loss by half, but the improvement came alongside continued cash burn, heavy equity issuance and an auditor-highlighted material uncertainty over its ability to continue as a going concern. The company is now relying on further funding while it prepares exploration programs in Ethiopia and Namibia.

VBX has expanded the Wuudagu Bauxite Project’s resource to 143.2 million tonnes, but its FY26 accounts expose acute funding pressure, with just $301,208 in cash and an auditor warning of material uncertainty over going concern. The definitive feasibility study has been pushed into the first quarter of 2027 while the company relies on fresh equity, related-party funding and prospective strategic partners.

Empire Resources has expanded its Yuinmery exploration story with new copper, gold and PGE zones, but its FY2026 annual report carries a material uncertainty over whether the company can continue as a going concern. A $4.825 million capital raising lifted cash, yet losses and director-related debt also increased.

Vectus Biosystems swung to a $1.56 million FY2026 profit, but the result was driven largely by the sale of its VB4-P5 compound for XORTX shares and warrants rather than recurring operations. The company is now directing its resources towards VB0004 while its auditor flags material uncertainty over ongoing funding.

Globe Metals & Mining has locked in a US$600,000 unsecured working capital facility from director Bo Tan, adding short-term financial flexibility as it advances its Kanyika Niobium Project.

Jade Gas Holdings has secured regulatory approvals for Mongolia’s first coal bed methane reserves, completed a A$12 million capital raise, and signed a non-binding A$1.1 billion collaboration agreement to fund initial development of its Red Lake gasfield.

Zelira Therapeutics has raised nearly US$33 million into its HOPE® 1 special purpose vehicle, valuing the SPV at about US$66 million post-money. The funds will advance FDA regulatory submissions and Phase 1 clinical trials for its autism-targeting cannabinoid drug.

Genmin has locked in A$3 million in unsecured director loans to fund working capital for its Baniaka iron ore project, avoiding immediate shareholder dilution while advancing project financing.

Aldoro Resources has secured A$4.3 million through unsecured convertible notes, providing funding to accelerate development at its Kameelburg Critical Minerals Project and exploring a potential Hong Kong Stock Exchange listing.

Careteq Limited’s strategic investor Antanas Guoga has converted all his convertible notes into shares, wiping out the company’s convertible debt and simplifying its capital structure ahead of its AI healthtech growth push.

Papyrus Australia has secured a key milestone under its TBS Mining Contract by executing a board production deal with a Vietnam manufacturer, while raising $325,000 to support commercial scale-up and facility establishment.

Careteq Limited has cleared $125,000 in director and company secretary loans a month ahead of schedule, using proceeds from a recent $2.2 million capital raising. This move strengthens the healthtech firm’s balance sheet and removes related-party debt ahead of maturity.